PREVENTION OF T-CELL ANERGY BY SIGNALING THROUGH THE GAMMA(C) CHAIN OF THE IL-2 RECEPTOR

被引:318
作者
BOUSSIOTIS, VA
BARBER, DL
NAKARAI, T
FREEMAN, GJ
GRIBBEN, JG
BERNSTEIN, GM
DANDREA, AD
RITZ, J
NADLER, LM
机构
[1] HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV PEDIAT ONCOL,BOSTON,MA 02115
[3] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV CELLULAR & MOLEC BIOL,BOSTON,MA 02115
[4] HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115
关键词
D O I
10.1126/science.7973657
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
When stimulated through their antigen receptor without requisite costimulation, T cells enter a state of antigen-specific unresponsiveness, termed anergy. In this study, signaling through the common gamma chain of the interleukin-2 (IL-2), IL-4, and IL-7 receptors in the presence of antigen was found to be sufficient to prevent the induction of anergy. After culture with IL-2, IL-4, or IL-7, Jak3 kinase was tyrosine-phosphorylated, which correlated with the prevention of anergy. Therefore, a signal through the common gamma chain may regulate the decision of T cells to either clonally expand or enter a state of anergy.
引用
收藏
页码:1039 / 1042
页数:4
相关论文
共 51 条
[1]   ERYTHROPOIETIN AND INTERLEUKIN-2 ACTIVATE DISTINCT JAK KINASE FAMILY MEMBERS [J].
BARBER, DL ;
DANDREA, AD .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (10) :6506-6514
[2]   REVERSAL OF INVITRO T-CELL CLONAL ANERGY BY IL-2 STIMULATION [J].
BEVERLY, B ;
KANG, SM ;
LENARDO, MJ ;
SCHWARTZ, RH .
INTERNATIONAL IMMUNOLOGY, 1992, 4 (06) :661-671
[3]  
BHANDOOLA A, 1993, J IMMUNOL, V151, P2355
[4]   B7 BUT NOT INTERCELLULAR-ADHESION MOLECULE-1 COSTIMULATION PREVENTS THE INDUCTION OF HUMAN ALLOANTIGEN-SPECIFIC TOLERANCE [J].
BOUSSIOTIS, VA ;
FREEMAN, GJ ;
GRAY, G ;
GRIBBEN, J ;
NADLER, LM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) :1753-1763
[5]  
BOUSSIOTIS VA, UNPUB
[6]  
BOUSSIOTIS VA, IN PRESS J EXP MED
[7]   PERIPHERAL TOLERANCE TO ALLOANTIGEN RESULTS FROM ALTERED REGULATION OF THE INTERLEUKIN-2 PATHWAY [J].
DALLMAN, MJ ;
SHIHO, O ;
PAGE, TH ;
WOOD, KJ ;
MORRIS, PJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (01) :79-87
[8]   INTERLEUKIN-2 (IL-2) RECEPTOR-GAMMA CHAIN MUTATIONS IN X-LINKED SEVERE COMBINED IMMUNODEFICIENCY DISEASE RESULT IN THE LOSS OF HIGH-AFFINITY IL-2 RECEPTOR-BINDING [J].
DISANTO, JP ;
DAUTRYVARSAT, A ;
CERTAIN, S ;
FISCHER, A ;
DESAINTBASILE, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (02) :475-479
[9]  
ESSERY G, 1988, IMMUNOLOGY, V64, P413
[10]  
FANSLOW WC, 1993, BLOOD, V81, P2998